Jay Bradner
President, Novartis Institutes | Pioneering Cancer Immunotherapy
About
Jay Bradner is a physician-scientist at the forefront of cancer research. As President of the Novartis Institutes for BioMedical Research, he oversees a global team exploring breakthrough therapies, including innovative cancer immunotherapy approaches.
Bradner's work has been published in top scientific journals like Nature and Science, and he holds numerous patents for novel cancer drugs. His keynotes provide a glimpse into the future of medicine, sharing transformative developments that are saving and extending lives.
Talks1
Open-source cancer research
How does cancer know it's cancer? At Jay Bradner's lab, they found a molecule that might hold the answer, JQ1. But instead of patenting it and reaping the profits (as many other labs have done) -- they published their findings and mailed samples to 40 other labs to work on. An inspiring look at the open-source future of medical research.
At a Glance
Is this you?
Claim this profile to edit your bio, add talks, and get verified.
Know a talk we're missing?
Get in Touch
Save for Later
Similar Speakers
Speakers with related expertise
Scott Williams
Computational Biologist | Pioneering Human Genome Research
Russ Altman
Professor of Bioengineering | Pioneering Artificial Intelligence in Medicine
David R. Liu
Professor of Chemistry | Gene Editing Pioneer
Martine Rothblatt
Transhumanist Entrepreneur | Pioneering Organ Transplants & AI Ethics